• OPEN AN ACCOUNT
Indian Indices
Sensex
71,560.26 -32.98
( -0.05%)
Global Indices
Nasdaq
51,245.91 45.04
(0.09%)
Dow Jones
7,786.38 -36.39
(-0.47%)
Hang Seng
69,343.08 -692.63
(-0.99%)
Nikkei 225
10,441.54 -16.96
(-0.16%)
Forex
USD-INR
96.37 0.10
(0.10%)
EUR-INR
108.33 0.45
(0.42%)
GBP-INR
127.68 0.44
(0.34%)
JPY-INR
0.61 0.00
(0.01%)

EQUITY - MARKET SCREENER

Brooks Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
533543
INE650L01011
41.0235362
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BROOKS
45.46
207.56
EPS(TTM)
Face Value()
Div & Yield %
1.55
10
0
 

Kilitch Drugs (India) consolidated net profit rises 39.62% in the March 2026 quarter
May 16,2026
Net profit of Kilitch Drugs (India) rose 39.62% to Rs 14.52 crore in the quarter ended March 2026 as against Rs 10.40 crore during the previous quarter ended March 2025. Sales rose 46.33% to Rs 89.60 crore in the quarter ended March 2026 as against Rs 61.23 crore during the previous quarter ended March 2025.

For the full year,net profit rose 13.00% to Rs 30.17 crore in the year ended March 2026 as against Rs 26.70 crore during the previous year ended March 2025. Sales rose 18.73% to Rs 235.47 crore in the year ended March 2026 as against Rs 198.32 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales89.6061.23 46 235.47198.32 19
OPM %24.7223.83 -15.5415.87 -
PBDT21.1914.69 44 42.2837.58 13
PBT20.2113.84 46 38.6534.47 12
NP14.5210.40 40 30.1726.70 13